In this work, we use clinical HCC samples and a series of HCC preclinical models to demonstrate the role of HKDC1 in promoting tumor immune evasion by coupling STAT1 activation with the cellular cytoskeleton to enhance PD-L1 expression in HCC cells. The gene discussed is CD274; the disease is neoplasm.